Atypical Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Atypical Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia [Phase 2]
Phase 2 trial update evaluating topotecan hydrochloride and carboplatin with or without veliparib for advanced myeloproliferative disorders …
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating ruxolitinib phosphate in patients with atypical chronic myeloid leukemia (BCR-ABL1 negative) and chronic neutrophil…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial evaluated imatinib (Gleevec) for chronic myelomonocytic leukemia, chronic myeloid leukemia, and atypical chronic my…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases [Phase 1]
Phase 1 trial update on belinostat plus azacitidine in adults with advanced hematologic cancers. The study has completed enrollment and eval…